國立虎尾科技大學 |

Acute Kidney Injury and Regenerative Medicine

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Acute Kidney Injury and Regenerative Medicine / edited by Yoshio Terada, Takashi Wada, Kent Doi.
其他作者:	Doi, Kent.
面頁冊數:	IX, 396 p. 39 illus., 33 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Regenerative Medicine/Tissue Engineering. -
電子資源:	https://doi.org/10.1007/978-981-15-1108-0
ISBN:	9789811511080

Acute Kidney Injury and Regenerative Medicine
Acute Kidney Injury and Regenerative Medicine [electronic resource] /edited by Yoshio Terada, Takashi Wada, Kent Doi. - 1st ed. 2020. - IX, 396 p. 39 illus., 33 illus. in color.online resource.

Part 1 Diagnosis and risk factors of AKI -- Definition and epidemiology of AKI -- Cause of AKI (prerenal, renal, postrenal) -- Pathophysiology of AKI -- Diagnosis of AKI (clinical assessment, novel biomarkers) -- Risk factors for AKI development in surgery -- Risk factors for AKI development in heart failure -- 7. Contrast-induced AKI -- 8. Antibiotics- and immunosuppression-related AKI -- 9. AKI in setting of cancer -- Community-acquired AKI and hospital-acquired AKI -- Part 2 Complication of AKI -- 11. Complication of homeostasis (mineral and acid-base) -- 12. Volume overload and cardiac and pulmonary complication -- Part 3 Prevention and management of AKI -- Prerenal and renal AKI -- Postrenal AKI -- AKI in intensive care medicine -- Nondialytic supportive management of AKI -- Renal replacement therapy in AKI -- Outcomes and long-term follow-up of AKI patients -- Prevention and management of pediatric AKI -- Part 4 Experimental novel findings -- AKI-to-CKD transition -- AKI and nerve system -- AKI and immune system -- AKI and cytokines -- Part 5 AKI and regenerative medicine -- iPS cell and renal regenerative medicine -- Embryonic genes and renal regenerative medicine -- Xenotransplanted embryonic kidney.

This book presents up-to-date information on the clinical-pathophysiological features of acute renal injury and discusses the KDIGO diagnostic criteria, as well as novel experimental findings, including in the area of regenerative medicine. It also highlights the clinical-pathophysiological importance of AKI in clinical settings, including differential diagnoses and management of AKI. In the past, the pathology associated with sudden renal impairment was characterized as acute renal failure (ARF). However, in the 2000s, the joint efforts of specialists in fields including nephrology, intensive care medicine, and cardiovascular medicine led to the introduction of a novel concept known as acute kidney injury (AKI). As medical care progressed, patients such as high-risk elderly subjects who were not deemed to be candidates for invasive therapy came to be treated in intensive care units (ICUs). As a result, kidney injury as a subset of multiple organ failure was re-considered as AKI, especially in intensive care medicine. AKI was then proposed as a novel disease concept to emphasize the importance of early diagnosis and early intervention to improve prognosis. Presenting novel features, such as the definition of AKI, risk factors and management; biomarkers, such as neutrophil gelatinase-associated lipocalin (NGAL) and L-type fatty acid-binding protein (L-FABP); long-term outcomes of AKI; as well as renal regeneration using iPS cell, manipulation of embryonic genes, and Xenotransplanted embryonic kidney, this book is of interest to all physicians and researchers in this field around the globe.

ISBN: 9789811511080

Standard No.: 10.1007/978-981-15-1108-0doiSubjects--Topical Terms:

1020916
Regenerative Medicine/Tissue Engineering.

LC Class. No.: RC902-918

Dewey Class. No.: 616.61

Acute Kidney Injury and Regenerative Medicine
LDR:04179nam a22003975i 4500 001 1026482
003 DE-He213
005 20200630215255.0
007 cr nn 008mamaa
008 210318s2020 si | s |||| 0|eng d
020 $a 9789811511080 $9 978-981-15-1108-0
024 7 $a 10.1007/978-981-15-1108-0 $2 doi
035 $a 978-981-15-1108-0
050 4 $a RC902-918
072 7 $a MJR $2 bicssc
072 7 $a MED055000 $2 bisacsh
072 7 $a MJR $2 thema
082 0 4 $a 616.61 $2 23
245 1 0 $a Acute Kidney Injury and Regenerative Medicine $h [electronic resource] / $c edited by Yoshio Terada, Takashi Wada, Kent Doi.
250 $a 1st ed. 2020.
264 1 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2020.
300 $a IX, 396 p. 39 illus., 33 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Part 1 Diagnosis and risk factors of AKI -- Definition and epidemiology of AKI -- Cause of AKI (prerenal, renal, postrenal) -- Pathophysiology of AKI -- Diagnosis of AKI (clinical assessment, novel biomarkers) -- Risk factors for AKI development in surgery -- Risk factors for AKI development in heart failure -- 7. Contrast-induced AKI -- 8. Antibiotics- and immunosuppression-related AKI -- 9. AKI in setting of cancer -- Community-acquired AKI and hospital-acquired AKI -- Part 2 Complication of AKI -- 11. Complication of homeostasis (mineral and acid-base) -- 12. Volume overload and cardiac and pulmonary complication -- Part 3 Prevention and management of AKI -- Prerenal and renal AKI -- Postrenal AKI -- AKI in intensive care medicine -- Nondialytic supportive management of AKI -- Renal replacement therapy in AKI -- Outcomes and long-term follow-up of AKI patients -- Prevention and management of pediatric AKI -- Part 4 Experimental novel findings -- AKI-to-CKD transition -- AKI and nerve system -- AKI and immune system -- AKI and cytokines -- Part 5 AKI and regenerative medicine -- iPS cell and renal regenerative medicine -- Embryonic genes and renal regenerative medicine -- Xenotransplanted embryonic kidney.
520 $a This book presents up-to-date information on the clinical-pathophysiological features of acute renal injury and discusses the KDIGO diagnostic criteria, as well as novel experimental findings, including in the area of regenerative medicine. It also highlights the clinical-pathophysiological importance of AKI in clinical settings, including differential diagnoses and management of AKI. In the past, the pathology associated with sudden renal impairment was characterized as acute renal failure (ARF). However, in the 2000s, the joint efforts of specialists in fields including nephrology, intensive care medicine, and cardiovascular medicine led to the introduction of a novel concept known as acute kidney injury (AKI). As medical care progressed, patients such as high-risk elderly subjects who were not deemed to be candidates for invasive therapy came to be treated in intensive care units (ICUs). As a result, kidney injury as a subset of multiple organ failure was re-considered as AKI, especially in intensive care medicine. AKI was then proposed as a novel disease concept to emphasize the importance of early diagnosis and early intervention to improve prognosis. Presenting novel features, such as the definition of AKI, risk factors and management; biomarkers, such as neutrophil gelatinase-associated lipocalin (NGAL) and L-type fatty acid-binding protein (L-FABP); long-term outcomes of AKI; as well as renal regeneration using iPS cell, manipulation of embryonic genes, and Xenotransplanted embryonic kidney, this book is of interest to all physicians and researchers in this field around the globe.
650 2 4 $a Regenerative Medicine/Tissue Engineering. $3 1020916
650 0 $a Tissue engineering. $3 558489
650 0 $a Regenerative medicine. $3 782729
650 0 $a Nephrology. $3 668354
700 1 $a Doi, Kent. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1322795
700 1 $a Wada, Takashi. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1322794
700 1 $a Terada, Yoshio. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1322793
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9789811511073
776 0 8 $i Printed edition: $z 9789811511097
776 0 8 $i Printed edition: $z 9789811511103
856 4 0 $u https://doi.org/10.1007/978-981-15-1108-0
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)